Clinical study of EPB-001
Latest Information Update: 19 Jan 2022
At a glance
- Drugs EPB-001 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
Most Recent Events
- 19 Jan 2022 New trial record
- 12 Jan 2022 According to a Elpis Biopharmaceuticals media release, the company expect to initiate this trial in 2023.